Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women

Ogilvie, Gina; Krajden, Mel; Maginley, Juanita; Isaac-Renton, Judy; Hislop, Greg; Elwood-Martin, Ruth; Sherlock, Chris; Taylor, Darlene; Rekart, Michael
August 2007
CMAJ: Canadian Medical Association Journal;8/28/2007, Vol. 177 Issue 5, p480
Academic Journal
To study the feasibility of self-collected specimens for testing human papillomavirus (HPV) status among hard-to-reach women, outreach nurses recruited women in women's centres, shelters and alleys in Vancouver's Downtown Eastside. Of the 151 participants for whom samples were available, 43 (28.5%) tested positive for high-risk HPV. Outreach nurses were able to recontact 81.4% of the participants who tested positive and referred them for further testing. About 14% (21/151) of participants had never received a Papanicolaou smear in British Columbia, as compared with 8.3% (608/7336) of women in the BC general population ( p< 0.05). This difference suggests that self-collection of specimens for HPV testing is a feasible method to reach women who have not previously participated in cervical cancer screening programs.


Related Articles

  • The role of human papillomavirus testing in cervical cancer screening. Morasse, Lauren; Davidov, Adi; Castellanos, Mario R. // JAAPA: Journal of the American Academy of Physician Assistants (;Nov2009, Vol. 22 Issue 11, p20 

    The article evaluates the cervical cancer screening guidelines with a focus on the role the human papillomavirus (HPV) testing. It states that the two screening methods include the conventional Pap smear where a sample of cervical cells are placed directly on a slide and the liquid-based...

  • INDIA: EPIDEMIOLOGY AND SCREENING OF CERVICAL CANCER. Bhatla, Neerja // Infectious Diseases in Obstetrics & Gynecology;2006, Vol. 2006, p8 

    Epidemiology of cervical cancer in India. Cervical cancer is the most common neoplasm in Indian women, with 126 000 new cases and 70 000 deaths each year. Incidence is higher than in Eastern Asia [1]. Across India, AARs vary greatly from ∼ 55/100 000 in Ambillikai to < 18 in Mumbai and...

  • What every woman should know about cervical cancer.  // Sister Namibia;Dec2010, Vol. 22 Issue 4, p24 

    The article offers information on how to prevent and detect cervical cancer. Cervical cancer could be prevented by having a Pap-smear once a year to detect changes due to infection and getting vaccinated against Human Papilloma Virus (HPV), which can be transmitted sexually. It notes that...

  • paps: an update,.  // Parenting School Years;Mar2009, Vol. 23 Issue 2, p28 

    The article presents the HPV DNA test cervical cancer screening tool approach as an alternative to the traditional PAP smear test. It suggests that although both tests provide protection in the prevention of cervical cancer, the HPV approach is more accurate, thus reducing unnecessary follow-up...

  • Liquid based cytology. Masenya, M. // Obstetrics & Gynaecology Forum;Aug2011, Vol. 21 Issue 3, p9 

    The human papilloma virus has been shown to play a significant aetiological role in invasive cervical cancer. The changes caused by human papilloma virus can be evaluated using Pap smear. The discovery of Pap smears has led to an unprecedented dramatic decline in the incidence of cervical cancer...

  • ORGANISATIONAL ASPECTS OF SUCCESSFUL SCREENING PROGRAMMES IN DEVELOPED COUNTRIES: THE ENGLISH MODEL. Kitchener, Henry // Infectious Diseases in Obstetrics & Gynecology;2006, Vol. 2006, p6 

    Assessing benefits, risks, and costs of cancer screening In planning a cancer screening programme, each country will develop guidelines based on the best available estimates of costs, benefits, and risks. Guidelines can be reviewed in light of emerging evidence as well as new diagnostic and...

  • The Test You're Probably NOT Getting.  // Good Housekeeping;Apr2010, Vol. 250 Issue 4, p55 

    The article focuses on screening for cervical cancer in women. The author notes that a more sensitive way to screen for cervical cancer is the human papillomavirus (HPV) test. The effectiveness of the test is discussed and a comparison with the traditional Pap test is given. Guidelines for both...

  • Cervical Cancer Awareness Month -- January 2013.  // MMWR: Morbidity & Mortality Weekly Report;1/4/2013, Vol. 61 Issue 51/52, p1049 

    The article focuses on January 2013 as Cervical Cancer Awareness Month. Both screening tests and vaccines are available for the prevention of human papillomavirus (HPV). It notes the occurrence of cervical cancer in women who rarely or have never screened for cancer. Pap tests are recommended...

  • Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era. Tota, Joseph; Mahmud, Salaheddin M.; Ferenczy, Alex; Coutlée, François; Franco, Eduardo L. // Sexual Health (14485028);Sep2010, Vol. 7 Issue 3, p376 

    The article presents information on a study which examined the expected effect of human papillomavirus (HPV) vaccination on cervical cancer screening and a possible new strategy that integrates novel molecular-based screening technologies. It discusses the immediate and long-term effects of HPV...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics